Top Markets
#1 MarsCoin MarsCoin +44.69%
#2 Palladium Network Palladium Network +27.94%
#3 Siren Siren +26.64%
#4 Status Status +22.00%
#5 Useless Coin Useless Coin +18.14%
#6 BankrCoin BankrCoin +15.32%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
#8 Ankr Network Ankr Network +12.62%
#9 Hive Hive +11.82%
#10 Bedrock Bedrock +11.80%
Coin of the day
MarsCoin MarsCoin
Settings
Language
ENGLISH
Currency
USD
Theme
ToolGen Incorporated ToolGen Incorporated

ToolGen Incorporated

199800
Rank in Stocks #18189
ToolGen Incorporated is a biotechnology enterprise based in South Korea,... ToolGen Incorporated is a biotechnology enterprise based in South Korea, primarily focused on pioneering advancements in genome editing technology. The company's main endeavor involves engineering CRISPR-Cas9 genetic modification tools specifically designed for editing genes in eukaryotic cells. Furthermore, its operations extend to commercializing its intellectual property, exploring therapeutic applications, and participating in the seed sector. Established in 1999, ToolGen's corporate headquarters are situated in Seoul, South Korea.
Share Price
$23.27
Market Cap
$209.31M
Change (1 day)
-1.32%
Change (1 year)
-6.48%
Country
KR
Trade ToolGen Incorporated (199800)

Category

Healthcare
P/E ratio for ToolGen Incorporated (199800)
P/E ratio as of 2026 TTM: 0
According to ToolGen Incorporated latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for ToolGen Incorporated from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
STERIS plc STERIS plc
STERIS plc
STE.US
 28.37 -
IE
Shanghai United Imaging Healthcare Co., Ltd. Shanghai United Imaging Healthcare Co., Ltd.
Shanghai United Imaging Healthcare Co., Ltd.
688271.SS
 - -
CN
Ypsomed Holding AG Ypsomed Holding AG
Ypsomed Holding AG
YPSN.SW
 - -
CH
Medacta Group S.A. Medacta Group S.A.
Medacta Group S.A.
MOVE.SW
 - -
CH
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.
Jafron Biomedical Co.,Ltd.
300529.SZ
 - -
CN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.